FDA Approves Wegovy Weight-Loss Pill

By News Health
1 hour Ago

(MedPage Today) — The FDA approved a pill version of the GLP-1 receptor agonist semaglutide (Wegovy), making it the first oral GLP-1 agent indicated for weight loss, Novo Nordisk announced on Monday.
The once-daily 25 mg pill is approved to lower…

Source link : https://www.medpagetoday.com/endocrinology/obesity/119154

Author :

Publish date : 2025-12-23 14:25:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

The Promise of Biomarkers to Direct Chronic Spontaneous Urticaria Therapy

FcRn Blockers Vie to Become First Approved Drug for Sjogren's Disease

EU Calls for Heart Health Plans Amid Rising Disease Burden

Here's Where Measles Case Counts Are Highest

How Is Frailty Linked With Cardiovascular Disease Events?

Medicare’s New WISeR Spending Model: 5 Things to Know